Right orbitofrontal rTMS benefits patients with treatment-resistant depression after unsuccessful DLPFC rTMS

• Ylka Kolken,
• Christina Tuttle,
• Joris van Neijenhof,
• Richard Pitch,
• Iris van Oostrom,
• Jonathan Downar,
• Martijn Arns,
• Nikita van der Vinne

Affiliations

Ylka Kolken

Research Institute Brainclinics, Brainclinics Foundation, Nijmegen, The Netherlands; Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands

Christina Tuttle

Long Island Neurocare Therapy, Long Island, NY, United States Minor Outlying Islands

Joris van Neijenhof

Neurocare Group, Nijmegen, The Netherlands

Richard Pitch

Long Island Neurocare Therapy, Long Island, NY, United States Minor Outlying Islands

Iris van Oostrom

Neurocare Group, Nijmegen, The Netherlands

Jonathan Downar

Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Toronto, ON, Canada; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada

Martijn Arns

Research Institute Brainclinics, Brainclinics Foundation, Nijmegen, The Netherlands; Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands; Neurocare Group, Nijmegen, The Netherlands

Nikita van der Vinne

Synaeda Psycho Medisch Centrum, Drachten, The Netherlands; Research Institute Brainclinics, Brainclinics Foundation, Nijmegen, The Netherlands; Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands